1. Home
  2. ENOV vs CDE Comparison

ENOV vs CDE Comparison

Compare ENOV & CDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • CDE
  • Stock Information
  • Founded
  • ENOV 1995
  • CDE 1928
  • Country
  • ENOV United States
  • CDE United States
  • Employees
  • ENOV N/A
  • CDE N/A
  • Industry
  • ENOV Fluid Controls
  • CDE Precious Metals
  • Sector
  • ENOV Industrials
  • CDE Basic Materials
  • Exchange
  • ENOV Nasdaq
  • CDE Nasdaq
  • Market Cap
  • ENOV 2.1B
  • CDE 2.4B
  • IPO Year
  • ENOV 2008
  • CDE N/A
  • Fundamental
  • Price
  • ENOV $31.56
  • CDE $7.81
  • Analyst Decision
  • ENOV Strong Buy
  • CDE Strong Buy
  • Analyst Count
  • ENOV 5
  • CDE 4
  • Target Price
  • ENOV $58.00
  • CDE $8.00
  • AVG Volume (30 Days)
  • ENOV 1.1M
  • CDE 17.5M
  • Earning Date
  • ENOV 05-08-2025
  • CDE 05-07-2025
  • Dividend Yield
  • ENOV N/A
  • CDE N/A
  • EPS Growth
  • ENOV N/A
  • CDE N/A
  • EPS
  • ENOV N/A
  • CDE 0.28
  • Revenue
  • ENOV $2,150,191,000.00
  • CDE $1,201,008,000.00
  • Revenue This Year
  • ENOV $8.13
  • CDE $60.06
  • Revenue Next Year
  • ENOV $6.19
  • CDE $1.36
  • P/E Ratio
  • ENOV N/A
  • CDE $27.69
  • Revenue Growth
  • ENOV 18.32
  • CDE 41.80
  • 52 Week Low
  • ENOV $29.32
  • CDE $4.57
  • 52 Week High
  • ENOV $51.10
  • CDE $7.98
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 36.65
  • CDE 69.05
  • Support Level
  • ENOV $30.65
  • CDE $7.54
  • Resistance Level
  • ENOV $37.85
  • CDE $7.98
  • Average True Range (ATR)
  • ENOV 1.31
  • CDE 0.36
  • MACD
  • ENOV -0.32
  • CDE 0.09
  • Stochastic Oscillator
  • ENOV 12.64
  • CDE 92.91

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About CDE Coeur Mining Inc.

Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada Mexico, and North America.

Share on Social Networks: